Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II).

Source:http://linkedlifedata.com/resource/pubmed/id/18069036

Download in:

View as

General Info

PMID
18069036